UK CyberKnife® expert Dr Andrew Gaya explains the technology and provides the essential information on this exciting new treatment option that everyone needs to know about cancer. Please see CyberKnife® Robotic Radiosurgery. The CyberKnife® Centre London at The Harley Street Clinic is the first of its kind in the UK. Investment in the latest CyberKnife® technology from the USA means that people who have been diagnosed with tumours and other medical conditions previously considered inoperable can now be treated.
CyberKnife® is also a treatment option for many cancers that previously required surgery, these include the following:
Brain
CyberKnife® provides finely focussed radiosurgical technology for delicate procedures.
Spine
Many of the vascular problems that occur in the brain also occur in the spine and CyberKnife® has marked advantages over other radiosurgical techniques in that it is capable of targeting spinal lesions.
Lung
Single or several tumours in the lung may be obliterated by single or a few fractions of CyberKnife® radiation therapy.
Prostate
CyberKnife® now offers a third radiotherapeutic method with potential to cure with equal success to IMRT methodology but with far fewer visits to the radiotherapy department for therapy.
Pancreas
CyberKnife® allows maximal deposition of radiation dose on the pancreatic tumour while sparing surrounding organs.
Liver
A focussed radiotherapy method that is able to spare the adjacent liver substance seems to have great merit and CyberKnife® perhaps optimally fulfils this role.
Kidney
Renal cancer is recognised as being one of the more radioresistant cancers and the need for higher dose therapy is restricted by the dose that surrounding tissues will tolerate. Focussed radiation therapy by CyberKnife® can be most useful in these situations. With its high degree of dose deposition accuracy, CyberKnife® may be the optimal method of delivering an ablative radiation dose.
Other cancers
There are always cancer patients referred into the cancer centre with sites of disease that have escaped orthodox therapy and remain as symptomatic sites of unablated disease. The use of cyberknife for discrete metastases is perceived to be an important advance.
Re-treatments
The ability of CyberKnife® to focally deposit high doses of ablative radiation on discrete sites of cancer has led to the safer re-treatment of cancers that may have re-grown after previous radiotherapy.
UK CyberKnife® expert Dr Andrew Gaya explains the technology and provides the essential information on this exciting new treatment option that everyone needs to know about cancer. Please see CyberKnife® Robotic Radiosurgery.
